Date published: 2025-10-26

1-800-457-3801

SCBT Portrait Logo
Seach Input

LRIG3 Activators

The LRIG3 protein is part of the LRIG family, which is characterized by containing leucine-rich repeat (LRR) and immunoglobulin (Ig)-like domains, features that are often involved in protein-protein interactions and can play roles in signaling pathways. To develop LRIG3 activators, a thorough understanding of the protein's structure and function would be essential. Researchers would first need to elucidate the protein's role in cellular processes and its interaction with other cellular components. Advanced techniques such as X-ray crystallography or cryo-electron microscopy might be used to determine the three-dimensional structure of LRIG3, revealing potential binding sites for activator molecules. Alongside structural studies, functional assays would be crucial to understand the consequences of LRIG3 activation within cells, providing a baseline against which the activity of potential activators could be measured.

Once potential binding sites have been identified, the search for LRIG3 activators would involve screening compound libraries to find molecules that can bind to and activate LRIG3. This process might use high-throughput screening assays to rapidly test thousands of compounds for their ability to modulate the protein's activity. Hits from these screens would represent initial candidates for LRIG3 activators and would be subjected to further testing and refinement. Subsequent optimization stages would involve chemical modifications to these hits to improve their selectivity, potency, and cellular uptake, ensuring that the molecules are effective at activating LRIG3 in the cellular context. This process would likely be iterative, with each round of modification informed by structure-activity relationship (SAR) studies that assess how changes to the compounds' structures affect their ability to activate LRIG3. Ultimately, the development of a class of LRIG3 activators would expand the set of molecular tools available for probing the role of this protein in cellular processes and could provide important insights into the function of LRIG3 within the biological context.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Dibutyryl-cAMP

16980-89-5sc-201567
sc-201567A
sc-201567B
sc-201567C
20 mg
100 mg
500 mg
10 g
$45.00
$130.00
$480.00
$4450.00
74
(7)

As a cAMP analog, db-cAMP can activate PKA and potentially influence transcription factors that upregulate LRIG3 expression.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$65.00
$319.00
$575.00
$998.00
28
(1)

Retinoic acid is involved in growth and differentiation; it could affect transcription factors that regulate LRIG3.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$42.00
$72.00
$124.00
$238.00
$520.00
$1234.00
11
(1)

EGCG has been shown to modify growth factor signaling, which could theoretically increase LRIG3 expression as a feedback mechanism.

Lithium

7439-93-2sc-252954
50 g
$214.00
(0)

Lithium influences Wnt signaling pathway, which might lead to changes in gene expression including potentially upregulating LRIG3.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$76.00
$150.00
$725.00
$1385.00
$2050.00
73
(3)

Forskolin activates adenylate cyclase, increasing cAMP levels and potentially influencing LRIG3 expression through PKA signaling pathways.

D,L-Sulforaphane

4478-93-7sc-207495A
sc-207495B
sc-207495C
sc-207495
sc-207495E
sc-207495D
5 mg
10 mg
25 mg
1 g
10 g
250 mg
$150.00
$286.00
$479.00
$1299.00
$8299.00
$915.00
22
(1)

Sulforaphane can activate Nrf2, a transcription factor that may indirectly upregulate growth factor-related genes like LRIG3.

Cholecalciferol

67-97-0sc-205630
sc-205630A
sc-205630B
1 g
5 g
10 g
$70.00
$160.00
$290.00
2
(1)

Vitamin D3 through its active metabolite can modulate gene expression, potentially affecting genes like LRIG3.

Metformin

657-24-9sc-507370
10 mg
$77.00
2
(0)

As an AMPK activator, metformin might influence cellular metabolism and growth, potentially impacting LRIG3 expression.

Pioglitazone

111025-46-8sc-202289
sc-202289A
1 mg
5 mg
$54.00
$123.00
13
(1)

A PPARγ agonist that may affect transcription of genes involved in growth factor signaling, potentially including LRIG3.

Dimethyloxaloylglycine (DMOG)

89464-63-1sc-200755
sc-200755A
sc-200755B
sc-200755C
10 mg
50 mg
100 mg
500 mg
$82.00
$295.00
$367.00
$764.00
25
(2)

DMOG inhibits prolyl hydroxylase, stabilizing HIF-1α and possibly affecting genes regulated by hypoxic responses, which may include LRIG3.